Acute Lymphoblastic Leukemia, Pediatric: Clinical Trials

35 trials for Acute Lymphoblastic Leukemia, Pediatric, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 recruiting, 12 completed, 5 unknown, 2 active not recruiting. 9 Not applicable, 8 Phase 2, 6 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable9Recruiting 5, Completed 3, Active not recruiting 1
Phase 28Recruiting 4, Completed 2, Terminated 1, Unknown 1
Phase 16Completed 2, Recruiting 2, Terminated 2
Phase 34Recruiting 2, Active not recruiting 1, Unknown 1

Follow Acute Lymphoblastic Leukemia, Pediatric: new trials by email Literature Review of Acute Lymphoblastic Leukemia, Pediatric trials Research Report on Acute Lymphoblastic Leukemia, Pediatric

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival
Acute Lymphoblastic Leukemia, Pediatric
RecruitingThe Children's Hospital of Zhejiang University School of Medicine5002025-08-012026-09-10
A Phase I Dose Finding Study of MB-CART2219.1
CAR-T cells targeting CD19 and CD22 - Lymphoma, CLL
Phase 1RecruitingUniversity Hospital Tuebingen362025-06-232025-08-07
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
TMLI, TBI, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric
Phase 2RecruitingThe First Affiliated Hospital of Zhengzhou University2762025-03-172025-02-18
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
TBI, TMLI, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric
Phase 2RecruitingThe First Affiliated Hospital of Zhengzhou University1702025-03-012025-02-18
Massage Impact on Sleep in Pediatric Oncology
Massage therapy, Standard of care - Cancer, Pediatric Cancer
Not applicableRecruitingChildren's Hospital of Philadelphia702025-01-232026-04-15
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
CareMeds Intervention, Usual Care Group - Acute Lymphoblastic Leukemia, Pediatric
Not applicableRecruitingRoswell Park Cancer Institute1002024-11-072026-04-23
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
Dasatinib(Sprycel) arm, Non-Dasatinib(Sprycel) arm - Acute Lymphoblastic Leukemia, Pediatric
Phase 2RecruitingHyoung Jin Kang742024-10-202026-07-29
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
MRF with neurocognative studies - Acute Leukemia, Acute Lymphoblastic Leukemia, Pediatric
Not applicableRecruitingCase Comprehensive Cancer Center202024-10-042026-10-20
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
Use of Virtual Reality Headset - Acute Lymphoblastic Leukemia, Pediatric
Not applicableRecruitingChildren's National Research Institute402024-08-302024-12-09
CD-19 CAR-T Cell for Pediatric ALL or Lymphoma
CAR-T - Lymphoma, B-Cell, Acute Lymphoblastic Leukemia, Pediatric
Not applicableRecruitingHong Kong Children's Hospital182024-05-012025-03-10
Determining the Mechanisms of Loss of CAR T Cell Persistence
Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia Not Having Achieved Remission
RecruitingUniversity College, London502023-10-182026-08-07
Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"
Self-report questionnaires (only for parents), Interview (only for parents), Clinical data collection (only concerning Children) - Acute Lymphoblastic Leukemia, Pediatric
UnknownCentre Leon Berard1812023-10-012023-10-30
Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.
lncRNA signature analyses - Acute Lymphoblastic Leukemia, Pediatric
UnknownIRCCS SYNLAB SDN202023-04-302024-04-03
Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation
Blinatumomab - Acute Lymphoblastic Leukemia, Pediatric
UnknownXiaojun Xu202023-04-012023-05-01
Vaccine Immune Recovery After Leukemia
Observational only: Serology and flow cytometry for ALL cohort participants, Observational only: Infection rates - Acute Lymphoblastic Leukemia, Pediatric
CompletedChildren's Hospital of Philadelphia892022-09-282026-01-26
Physical Exercise and Dairy Probiotics in Childhood Cancer Survivors
Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518, Physical exercise - Acute Lymphoblastic Leukemia, Pediatric
Not applicableCompletedComenius University292022-04-012024-01-16
Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children
Murine autologous anti-CD19 chimeric antigen receptor T cells - Acute Lymphoblastic Leukemia, Pediatric, Acute Lymphoblastic Leukemia, in Relapse
Phase 2CompletedBeijing Boren Hospital22022-03-242025-05-18
Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)
the risk-adapted choice of therapy and the use of a combination of chemotherapy with immunotherapy and hematopoietic stem cell transplantation for patients with risk factors. - Acute Lymphoblastic Leukemia, Pediatric, ALL, Infants
Phase 3RecruitingFederal Research Institute of Pediatric Hematology, Oncology and Immunology802021-09-232024-06-28
Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia
Curcumin, Standard of Care - Acute Lymphoblastic Leukemia, Pediatric
Phase 2CompletedAin Shams University302021-08-222024-01-08
Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia
Palbociclib, Dexamethasone, Bortezomib - Acute Lymphoblastic Leukemia, Pediatric, Relapsed Acute Lymphoblastic Leukemia
Phase 1CompletedTanja Andrea Gruber22021-07-092026-04-17

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (35)  ·  Lymphoma (3)  ·  Lymphoma, B-Cell (2)  ·  Neoplasms (2)  ·  Anxiety Disorders (1)  ·  Bone Diseases, Metabolic (1)  ·  Depression (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Leukemia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)

Broader conditions

Hematologic Diseases (35)  ·  Hemic and Lymphatic Diseases (35)  ·  Immune System Diseases (35)  ·  Immunoproliferative Disorders (35)  ·  Lymphatic Diseases (35)  ·  Lymphoproliferative Disorders (35)  ·  Neoplasms by Histologic Type (35)  ·  Leukemia (34)  ·  Leukemia, Lymphoid (34)  ·  Neoplasms (33)  ·  Lymphoma, Non-Hodgkin (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Behavior (2)  ·  Lymphoma (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Cyclophosphamide (6)  ·  Dexamethasone (4)  ·  Doxorubicin (3)  ·  Mercaptopurine (3)  ·  Asparaginase (2)  ·  Bortezomib (2)  ·  Calcium Dobesilate (2)  ·  Cytarabine (2)  ·  Etoposide (2)  ·  Methotrexate (2)  ·  Standard of Care (2)  ·  Vincristine (2)  ·  blinatumomab (2)  ·  fludarabine (2)  ·  pegaspargase (2)

Sponsors

The Children's Hospital of Zhejiang University School of Medicine (3)  ·  Children's Hospital of Philadelphia (2)  ·  The First Affiliated Hospital of Zhengzhou University (2)  ·  Ain Shams University (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Beijing Boren Hospital (1)  ·  Cairo University (1)  ·  Case Comprehensive Cancer Center (1)  ·  Centre Leon Berard (1)  ·  Children's National Research Institute (1)  ·  Cipherome, Inc. (1)  ·  Columbia University (1)  ·  Comenius University (1)  ·  Dana-Farber Cancer Institute (1)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)

Countries

United States (13)  ·  China (7)  ·  Germany (3)  ·  Egypt (2)  ·  Italy (2)  ·  Slovakia (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  Israel (1)

Top investigators

Anupam Verma, MD (1)  ·  Athanassios Evangeliou, Prof (1)  ·  Brian T Fisher, DO MSCE MPH (1)  ·  Elena Ladas, PhD (1)  ·  Elizabeth Bouchard, PhD (1)  ·  Giovanni Smaldone, PhD (1)  ·  Ihab Khairy, M.D (1)  ·  Julie-An Talano, MD (1)  ·  Kara Davis, MD (1)  ·  Kathleen M Sakamoto, MD, PhD (1)  ·  Laura D Bilek, PhD (1)  ·  Martin Schrappe, MD (1)  ·  Melissa Burns, MD (1)  ·  Pamela Lee, MD (1)

Results publications

PMID 21270794, PMID 23962279, PMID 25624441, PMID 31110096, PMID 33590674, PMID 34933343, PMID 35129146, PMID 36973774, PMID 37481608, PMID 37753808, PMID 38841802, PMID 39192036, PMID 40905823, PMID 41469545, PMID 41671463, PMID 42527400, PMID 42748428

NIH funding

2016 (1), R01CA258337 (1), R01NR019190 (1)